True sle. Extraordinarily undervalued this company with good prospects and the Sabah pertrloeum deal. Deserves re rating once the peak merger is resolved as well.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
